Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ahlsell aquires Arbetsklädshuset AB

Ahlsell has signed an agreement to acquire all shares in Arbetsklädshuset AB (AKH), a Swedish distributor of work wear and personal protection equipment. The company has 20 employees and has an annual turnover of approximately SEK 70 million.AKH was founded in 1889, and offers a wide range of products within workwear, profile clothing, shoes and personal protection equipment. AKH has four stores; in Uppsala, Västerås, Bromma and Hammarby Sjöstad. AKH will be part of Ahlsell Workwear, AWW. Closing is scheduled to take place in February 2020. For more information please contact:

#19-1173 Listing of Loan Debenture issued by Proventus Capital Partners IV AB (publ)

As from December 20, 2019, 1 loan debenture issued by Proventus Capital Partners IV AB (publ) will be listed on Miscellaneous Debt Securities SE. The instrument will be registered at Euroclear Sweden AB.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB         About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of

Herantis Pharma Plc completes patient treatments in main study of Phase 1-2 CDNF trial in Parkinson’s disease

Herantis Pharma PlcCompany release, insider information 19 Dec 2019 at 4:00 PM Eastern European TimeHerantis Pharma Plc (“Herantis” or “Company”) announced today having completed patient treatments as planned in the main study of the Company’s Phase 1-2 clinical trial examining Herantis’ proprietary neuroprotective factor and novel drug candidate CDNF in patients with Parkinson’s disease. Of the 17 patients randomized in the clinical trial, 15 patients completed the main study according to the study protocol and two patients discontinued due to reasons not related to CDNF. All 15 patients

Saab Receives Order for Gripen Support and Maintenance Operations

Saab has received an order from the Swedish Defence Materiel Administration (FMV) on behalf of the Swedish Armed Forces to provide support and maintenance services for Gripen during the first half of 2020. The order's total value amounts to approximately SEK 450 million.The order applies to services for the first six months of 2020 and is an extension of a previously signed contract with FMV regarding performance-based support and maintenance of Gripen. The contract was signed in late May 2017. The order includes support and maintenance services essential to aviation operations with Gripen.

Nasdaq Stockholm approves Hembla’s application for delisting of Hembla’s shares

On 18 December 2019, Hembla AB (publ) (“Hembla”) announced that the board of directors of Hembla has applied for delisting of the Hembla’s shares from Nasdaq Stockholm. On 19 December 2019, Nasdaq Stockholm has approved such application for delisting and has decided that the last day of trading of Hembla’s shares will be 10 January 2020. Stockholm on 19 December 2019         Hembla AB (publ)       The board of directors   For further information, please contact Jenny Wärmé, Head of Legal & Corporate Affairs, tfn +46 708 43 12 18 The information was released for publication

SDLP - Seadrill Partners LLC 2019 AGM Results Notification

London, United Kingdom, December 19, 2019 - Seadrill Partners LLC (the “Company”) advises that the 2019 Annual Meeting of the Members of the Company was held on December 19, 2019 at 11:00 am London time, at 2nd Floor, 566 Chiswick High Road, Building 11, Chiswick Business Park, London W4 5YS, United Kingdom. The following proposals were approved: To elect Andrew Cumming as a Class III Director of the Company whose term will expire at the 2022 Annual Meeting of Members; and To elect Keith MacDonald as a Class III Director of the Company whose term will expire at the 2022 Annual

STENOCARE sign strategic development partnership with Solural Pharma

STENOCARE A/S (“STENOCARE”) and Solural Pharma Aps (“Solural”) have signed a strategic Partnership Agreement to develop, test and commercialize advanced cannabis-based medical products.Next generation medical cannabisThe new relationship is in line with the STENOCARE 2.0 pharma-strategy; which is to supplement its high quality generic medical cannabis products with enhanced products that are specially formulated to target specific patient groups suffering from specific conditions. The first joint project will be a cannabis oil-based oral formulation, that will be developed and tested

#19-1172 Listing of Loan Debenture issued by Stabelo Fund 1 AB

As from January 9, 2020, 1 loan debenture issued by Stabelo Fund 1 AB will be listed on Miscellaneous Debt Securities SE. The instrument will be registered at Euroclear Sweden AB.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB       About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading

Director/PDMR Shareholding

19 December 2019 Independent Oil and Gas plc  Director & PDMR Dealing  Independent Oil and Gas plc ("IOG" or the "Company"), the development and production company focused on becoming a substantial UK gas producer, is pleased to announce that certain Directors and persons discharging managerial responsibilities ("PDMRs") of the Company have purchased in the market 397,434 ordinary shares of 1p each at an average price of 15.633p per share in the Company, equating to an aggregate value of £62,130.86. Share purchases and revised shareholdings are shown below: Director/ Role

Invitation to Alfa Laval’s fourth-quarter conference call

Alfa Laval will release fourth-quarter earnings on February 4[th] at 07:30 a.m. CET. The telephone conference will start at 08:30 a.m. CET.To join the telephone conference - hosted by Alfa Laval’s President and CEO, Tom Erixon, and CFO, Jan Allde - sign up in advance via the link below. Once registered, you will receive a phone number, a participant pin and a conference pin. Please dial in 10 minutes prior to the scheduled start of the event. http://emea.directeventreg.com/registration/7459933 You can also follow the conference via a live webcast. A webcast link will be available on

Outokumpu – Next plan period 2020–2022 for share-based programs and 2019 share rewards in Matching Share Plans

Outokumpu OyjStock exchange releaseDecember 19, 2019 at 3.30 pm EETOutokumpu – Next plan period 2020–2022 for share-based programs and 2019 share rewards in Matching Share Plans As part of the long-term incentive programs for key employees in Outokumpu, the Board of Directors has approved the commencement of the plan period 2020–2022 for the company’s share-based programs. Furthermore, the Board approved the deliveries of the 2019 share rewards in the Matching Share Plans for Management and CEO. Plan periods for share-based programs 2020–2022 The Board of Directors has now

John Mattson acquires 541 apartments in Sollentuna municipality

John Mattson Fastighetsföretagen AB (publ) has today signed an agreement to acquire 541 apartments in the Rotebro and Rotsunda districts of Sollentuna municipality. The purchase price amounts to SEK 765 million after deduction of deferred tax of SEK 40 million. The seller is Sollentuna Stadshus AB.The acquisition comprises 29 properties, with a total lettable area of 37,200 square metres, in attractive locations by Rotebro city centre and Rotsunda Torg, close to the commuter train station and the E4. Rotebro and Rotsunda are growing parts of Sollentuna municipality with positive population

Company Announcement No. 124, 2019 – EURIBOR3, Fixing of coupons with effect as from 1 January 2020

The coupons for the FRNs listed below will change taking effect 1 January 2020. The new coupons will be in force from 1 January 2020 – 31 March 2020. FRNs without interest rate cap, EURIBOR3: ISIN-code DK0002040138, maturity 2021, new coupon as per 1 January 2020:                      -0.10 % p.a. ISIN-code DK0002043231, maturity 2022, new coupon as per 1 January 2020:                      -0.13 % p.a. Questions can be directed to Torben Jurlander phone no. +45 55 47 41 99. Yours faithfully Nordea Kredit Realkreditaktieselskab

PRESS RELEASE

ARDIAN ACQUIRES Cérélia, A LEADING TRANSATLANTIC PROVIDER OF INNOVATIVE BAKERY SOLUTIONS FROM IK INVESTMENT PARTNERSParis and New York, December 19, 2019 - Ardian , a world leading private investment house, announced today that it is acquiring Cérélia  (“the Company”), from the IK VII Fund, advised by IK Investment Partners (“IK”).  Cérélia is a leading transatlantic provider of innovative bakery solutions with a product portfolio including ready-to-bake pie and pizza dough, pancakes, crepes and cookies.  The Company’s products provide

Digital-healthcare provider Accumbo initiates ‘Diabetesdoktorn’ with Brighter’s diabetes service Actiste®

Stockholm, Sweden – Brighter AB (publ.) (NASDAQ First North: BRIG), a leading digital-healthcare company, is pleased to announce that the Swedish digital-healthcare provider Accumbo is launching a pilot project in Sweden with Brighter’s Actiste® Diabetes Management as a Service. The project will integrate Actiste into the forthcoming Diabetesdoktorn  service ('The Diabetes Doctor'), which is an extension of Accumbo's current offering, Blodtrycksdoktorn ('The Blood Pressure Doctor'). "The collaboration between Accumbo and our service Actiste® means that

Orkla ASA: Mandatory notification of trade – primary insiders

Erik Nordby, deputy member of the Orkla Board, has sold 2,000 shares at an average price of NOK 89.00 per share. Following this transaction, Nordby and related parties own 2,885 shares in Orkla. Orkla ASAOslo, 19 December 2019Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Financial calendar 2020

H+H International A/S has planned the following release dates for the financial reports and the Annual General Meeting. 19 February 2020                  Deadline for shareholders for submission of proposals for the agenda of the Annual General Meeting 11 March 2020:                     Annual Report 2019               2 April 2020:                         Annual General Meeting 15 May 2020:                        Interim report for the first quarter of 2020 14 August 2020                     Interim report for the first half of 2020 13 November 2020                Interim

The Board of Directors of Valmet Oyj has decided on share-based incentive plans for key employees and on the acquisition of own shares

Valmet Oyj’s stock exchange release on December 19, 2019 at 2:30 p.m. EET The Board of Directors of Valmet Oyj has decided on a long-term share-based incentive plan (LTI Plan) and a restricted shares pool (Restricted Shares Pool) for Valmet's key employees. The aim of the plans is to combine the objectives of the shareholders and the key employees in order to increase the value of the Company in the long run, to commit the key employees to the Company, and to offer them a competitive reward plan based on holding the Company's shares. The LTI Plan includes three performance periods,

ZICCUM AB engages Emerging Viral Diseases unit of Aix-Marseille University to develop dry viruses and vaccines, strengthening Ziccum’s future IP portfolio

Lund, 19th December 2019. The Emerging Virus Unit (Unité des Virus Émergents) is one of the world’s leading virology laboratories. Ziccum has now engaged UVE to use Ziccum’s technology to develop and formulate vaccines and viruses as dry powders, boosting global access to them and making them significantly faster and cheaper to transport. This collaboration will significantly strengthen Ziccum’s IP portfolio.“Underimmunisation has never been more urgent” says Ziccum CEO Göran Conradson “this decision by Unité des virus émergents (UVE) to collaborate and develop the use of our technology to

Pandox has received a decision from the Swedish Tax Authority regarding the Group’s transfer pricing

Pandox AB (publ) (“Pandox or the Company”) has received a decision from the Swedish Tax Authority regarding the Group’s transfer pricing.Pandox’s transfer pricing does not differ from industry practice. The Swedish Tax Authority is however of the opinion that allocation of profits shall not be made to the country where the operations are conducted but to the country of the parent company, i.e., Sweden. Pandox insists that the Group’s companies are following and have followed applicable laws for taxation in the countries where the Group’s companies are operating and will appeal the decision.

Cimco Marine AB (publ) formalizes its agreement in principle with the European Investment Bank

Cimco Marine AB (publ) (“Cimco”) on 9 October 2019 announced that Cimco had reached an agreement in principle with the European Investment Bank (“EIB”) that also directed share issues at a subscription price of SEK 1.5 per share will count towards fulfilment of the conditions precedent for Tranche B under the parties’ credit facility agreement. The agreement in principle has now been documented in a formal agreement between the parties. Following the successful directed share issue of SEK 17.2 million in October 2019, the relevant condition precedent for Tranche B is now fulfilled.On 5 July

Despite clamour for change, citizens think corruption is worsening in the Middle East and North Africa

New corruption survey shows two thirds of people think their government is performing badlyA new report by Transparency International reveals that only 28 per cent of citizens in six countries in the Middle East and North Africa think their government is doing a good job at fighting corruption. In a region that has seen mass protests against corruption in 2019, two in every three (65 per cent) citizens think that corruption increased in the previous 12 months. Read the report  The report, Global Corruption

Ana-Maria Matei new Head of Internal Audit at Swedbank

Ana-Maria Matei most recently comes from Handelsbanken, where she has worked with Internal Audit at top management level for several years. She has over 18 years of experience in auditing, whereof mostly from senior assignments within the financial sector.The recruitment of Ana-Maria Matei as new Head of Internal Audit will help to further strengthen an important key function within the bank. She has a solid experience in auditing from authorities, the financial sector and the consulting industry. “The Board sees that the combination of her broad perspective, good insight into the work

Expanded pharmacy distribution of Peptonic’s VagiVital[®]

Stockholm, December 19[th], 2019 - Peptonic Medical AB (‘Peptonic’ or ‘Company’) today announces that Kronans Apotek and Apoteksgruppen have decided to carry Peptonic’s self-care product VagiVital® in 170 and 37 of their pharmacy retail shops, respectively, from w/c February 10[th], 2020. Until now, VagiVital® has been available for purchase on the webshop of Kronans Apotek and on order in Apoteksgruppen’s pharmacies. However, from mid February the availability of VagiVital® will be considerably improved in these pharmacies.In addition to now being for sale in Kronans Apotek and

There are no items matching the current filter
There are no more items matching the current filter
Back to top